In a study, a team of UCLA investigators detail a deep-learning model pre-trained on 2D scans that accurately predicts ...

The award from the National Institutes of Health will enable a team of researchers to investigate Alzheimer and Parkinson ...

Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

The donation will support the development of the Artificial Intelligence Innovation Center, a collaborative hub with a focus ...

CVD, an AI diagnostic solution that autonomously assesses future cardiovascular disease risk using a retina scan.

Proviant Therapeutics announced the first patients have been enrolled in CLARITY, its phase 3 study ( NCT06431373) evaluating ...

Because the inner retinal function is thought to affect the emmetropization process, authors suggested that caffeine may be ...

Adam S. Wenick, MD, PhD, chaired a symposium on geographic atrophy (GA) at EyeCon 2024, focusing on the diagnosis, monitoring ...

At EyeCon 2024, Analisa Arosemena, MD, discussed the shift away from traditional topical therapies towards more proactive ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The agency confirmed its June 2024 negative opinion after Apellis requested re-examination of EMA's initial opinion.

In a study, a team of Chinese researchers looked at the mechanisms behind the development of EI and explored effective ...